Related references
Note: Only part of the references are listed.Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications
Andreia Carona et al.
LIFE SCIENCES (2021)
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli et al.
PHARMACEUTICALS (2021)
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study
Margherita Barbuti et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2021)
Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?
Federico Cucchiara et al.
PHARMACOLOGICAL RESEARCH (2020)
Impact of gender, albumin, and CYP2C19 polymorphisms on valproic acid in Chinese patients: a population pharmacokinetic model
Jinlin Guo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Lithium Prescribing and Therapeutic Drug Monitoring in Bipolar Disorder: A Survey of Current Practices and Perspectives
Virginia Fernandes et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2020)
Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis
Agumasie Semahegn et al.
SYSTEMATIC REVIEWS (2020)
Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study
Louise Wingard et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Personalized and precision medicine as informants for treatment management of bipolar disorder
Giulio Perugi et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
C. Hiemke et al.
PHARMACOPSYCHIATRY (2018)
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism
Stefano Aringhieri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data
R. L. Smith et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Lithium side effects and toxicity: prevalence and management strategies
Michael Gitlin
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2016)
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study
Alberto Bocchetta et al.
BMC MEDICINE (2015)
Prescribing patterns of lithium or lithium plus valproate in manic or mixed episodes: a naturalistic study
Matteo Muti et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Yogita Ghodke-Puranik et al.
PHARMACOGENETICS AND GENOMICS (2013)
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
Andrea Cipriani et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder
Chi-Tso Chiu et al.
PHARMACOLOGICAL REVIEWS (2013)
Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study
Gregor E. Berger et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Sebastien Chateauvieux et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Low-Dose Divalproex in Agitated Patients with Alzheimer's Disease
Christian Dolder et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2010)
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial
John R. Geddes et al.
LANCET (2010)
Therapeutic Drug Monitoring of Lithium in Patients With Bipolar Affective Disorder: Experiences From a Tertiary Care Hospital in India
Sangeeta Sharma et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Bipolar disorder and mechanisms of action of mood stabilizers
Stanley I. Rapoport et al.
BRAIN RESEARCH REVIEWS (2009)
A review of valproate in psychiatric practice
Peter M. Haddad et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence
David E. Kemp et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
What is the optimal serum lithium level in the long-term treatment of bipolar disorder - a review?
W. E. Severus et al.
BIPOLAR DISORDERS (2008)
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Philip N. Patsalos et al.
EPILEPSIA (2008)
Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania
MH Allen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Cost-effectiveness of therapeutic drug monitoring - A systematic review
DJ Touw et al.
THERAPEUTIC DRUG MONITORING (2005)
Share Paper
